Imaging Services
Total Trials
2
As Lead Sponsor
0
As Collaborator
Total Enrollment
38
NCT03410030
Trial of Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM)
Phase: Phase 1/2
Role: Collaborator
Start: Dec 15, 2017
Completion: Jan 10, 2022
NCT03415854
Paclitaxel Protein Bound Plus Cisplatin Plus Gemcitabine and Paricalcitol for Pancreatic Adenocarcinoma (NABPLAGEMD)
Phase: Phase 2
Start: Jan 31, 2018
Completion: Dec 11, 2023
Loading map...